SIGN UPLog In

Last deal

$165K

Amount

Seed

Stage

11.05.2019

Date

3

all rounds

$1.6M

Total amount

General

About Company
Mati Therapeutics is a biotechnology company that develops drug delivery tools for the treatment of age-related macular degeneration.

Industry

Sector :

Subsector :

Keywords :

Also Known As

10152012, Inc.

founded date

01.01.2012

Number of employees

11-50

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The company specializes in using tear film technology to deliver drugs to the surface of the eye, providing therapeutic agents for dry eye syndrome and ocular allergies. Founded in 2012, Mati Therapeutics is focused on developing a platform for sustained drug delivery to the eye.
Contacts

location

Austin, TX, USA

Phone number

Website URL

http://www.matitherapeutics.com